Navigation Links
China Yingxia International, Inc. Appoints Chief Financial Officer
Date:6/16/2008

HARBIN, China, June 16 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the nutraceutical industry engaged in the development, manufacture and distribution of organic nutritional food products, supplements, and personal care products in the People's Republic of China ("PRC"), today announced the appointment of Mr. Ren Hu as its new chief financial officer effective June 11, 2008.

Mr. Hu assumed responsibility as the Company's CFO on June 11, 2008 and will report directly to Ms. Yingxia Jiao, CEO of China Yingxia. Mr. Hu will be responsible for overseeing the Company's overall financial planning, control and reporting activities, SEC compliance, audit and investor relations. Mr. Hu has over 25 years of experience in business and finance, with expertise on Wall Street. Prior to joining China Yingxia, Mr. Hu worked as a vice president of finance at China Kangtai Cactus Bio-Tech, Inc. (OTCBB: CKGT), from June 2006 to June 2008, where he was in charge of North American operations, namely timely filing of SEC reports, investor relations, and capital raising. In addition, Mr. Hu worked as the vice president for Phoenix Forest, LLC., the US investment banking arm of Lin Feng Group, in 2005, executing a reverse merger transaction for a China based power plant, and as the president for China Finance, Inc. (OTCBB: CHFI) in 2004, overseeing investor relations.

Mr. Hu also has extensive brokerage house and hedge fund management and trading experiences and has/had FINRA (formerly NASD) securities licenses S7, S55 and S63. Mr. Hu received his MBA from London Business School in 1989 and MS in finance from Florida International University in 1994. He is currently an ABD (all-but-dissertation doctoral candidate) in international business at Rutgers University.

"We are very pleased to have Mr. Hu join China Yingxia as our chief financial officer," said Ms. Yingxia Jiao, CEO of China Yingxia. "Mr. Hu's prior experience working at one of our peer company's and a Chinahybrid, helps him in moving China Yingxia forward as well as helps our firm in its financial oversight and reporting capabilities," added Ms. Jiao.

"I am excited to join China Yingxia and look forward to working closely with Ms. Jiao and the rest of the team in accomplishing the Company's financial goals," commented Mr. Hu. "In addition, I look forward to working closely with the investment community in communicating the Company's financials."

About China Yingxia International, Inc.

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ('Yingxia'), is primarily engaged in the development, production and sales of health food products in China. Yingxia is located in the Province of Heilongjiang, Peoples Republic of China. Yingxia's products include soybean-based foods and drinks, longgu golden millet enriched products, cactus-based herbal supplements, personal care products, Nestle products, and organic rice products.

Safe Harbor Statement

The statements contained herein that are not historical facts are 'forward-looking statements' within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as 'believes,' 'expects,' 'may,' 'will,' 'should,' or 'anticipates,' vexpect' or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets or forecasting financial results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

For more information, please contact:

Company Contact:

Mr. Ren Hu

Chief Financial Officer

China Yingxia International, Inc

Tel: +1-201-887-0415

Email: arenhu@gmail.com

Investor Relations Contact:

Mr. Crocker Coulson

President

CCG Investor Relations

Tel: +1-646-213-1915

Email: crocker.coulson@ccgir.com

Website: http://www.ccgir.com


'/>"/>
SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. China Sky One Medical, Inc. to Acquire Peng Lai Jin Chuang Company
2. China Medical Technologies Reports Fourth Quarter and Full Year Financial Results
3. AmeriCares Establishes Field Hospital in China
4. China Sky One Medical, Inc. Announces Guidance for Second Quarter and Full Year 2008
5. AmeriCares Purchases BLU-MED Portable Hospital for China Earthquake Relief
6. Answers From Nature Introduces 100% Non-China Ingredients for Dietary Supplements
7. China Sky One Medical, Inc. Receives SFDA Approval for Five Patches
8. Meetings with Pre-Screened Verified China Suppliers Help 14 Top Buyers, Including Brookstone and Staples, Save Time and Cut Sourcing Costs
9. Free Wheelchair Mission to Distribute 4,400 Wheelchairs to China Earthquake Victims
10. China Nepstar Chain Drugstore Filed Its Annual Report on Form 20-F
11. China Sky One Medical, Inc. Donates RMB 1.1 Million in Medicine for Earthquake Disaster Relief Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... ... Inflow IQ & Inflownomics of Raleigh, NC introduce a powerful information access ... As experts in dangerous situations the Inflow IQ team can help people. Get ... clean & refreshing knowledge systems that enhance life. , Authentically enjoy ...
(Date:3/23/2017)... ... March 23, 2017 , ... The Leaders ... life-altering and fatal diseases in opposition to the President’s Fiscal Year 2018 ... care, services, and hope for the most vulnerable among us. , The proposed ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... with European Guidelines and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An ... http://www.fdanews.com/mdclineval                  , How will the new EU MDR language change ...
(Date:3/23/2017)... DC (PRWEB) , ... March 23, 2017 , ... News ... Dental Choice has helped score a major victory in Europe for public health and ... , Based on rigorous scientific research and the overwhelming support of European ...
(Date:3/23/2017)... ... March 23, 2017 , ... “My Journey Through Heaven”: the ... an infinitely more profound faith of God’s promise of Heaven for His people. “My ... spends each day with his wife, three children and six grandchildren living and doing ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... AVIV, Israel, March 23, 2017  Galmed Pharmaceuticals ... the "Company"), a clinical-stage biopharmaceutical company focused on ... the treatment of nonalcoholic steatohepatitis, or NASH, and ... the three and twelve months ended December 31, 2016, ... completed pre-clinical studies demonstrating Aramchol™,s potential direct effect ...
(Date:3/23/2017)... PUNE, India , March 23, 2017 ... 2022 report focuses on the Colposcope in Global market, especially in ... and Asia-Pacific , South America ... . This report categorizes the market based on manufacturers, regions, ... ...
(Date:3/23/2017)... SAN FRANCISCO , March 23, 2017 ... reach a value of USD 25.7 billion by 2025, according ... devices are expected to grow at a faster rate due ... to rising awareness about various types of esthetic procedures used ... from these disorders. Hence, they are considered as the highest ...
Breaking Medicine Technology: